These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 29570265)

  • 21. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.
    LaConti JJ; Laiakis EC; Mays AD; Peran I; Kim SE; Shay JW; Riegel AT; Fornace AJ; Wellstein A
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S1. PubMed ID: 25923219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Situ Detection of Plasma Exosomal MicroRNA-1246 for Breast Cancer Diagnostics by a Au Nanoflare Probe.
    Zhai LY; Li MX; Pan WL; Chen Y; Li MM; Pang JX; Zheng L; Chen JX; Duan WJ
    ACS Appl Mater Interfaces; 2018 Nov; 10(46):39478-39486. PubMed ID: 30350935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.
    Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
    Cancer Biomark; 2018 Feb; 21(3):505-511. PubMed ID: 29171983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic-Based Microfluidic Device for On-Chip Isolation and Detection of Tumor-Derived Exosomes.
    Xu H; Liao C; Zuo P; Liu Z; Ye BC
    Anal Chem; 2018 Nov; 90(22):13451-13458. PubMed ID: 30234974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case Report: Early detection of pancreatic pre-cancer lesion in multimodal approach with exosome liquid biopsy.
    Dhani H; Hinestrosa JP; Izaguirre-Carbonell J; Balcer HI; Kurzrock R; Billings PR
    Front Oncol; 2023; 13():1170513. PubMed ID: 37251939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases.
    Lucien F; Lac V; Billadeau DD; Borgida A; Gallinger S; Leong HS
    Oncotarget; 2019 Feb; 10(10):1045-1055. PubMed ID: 30800217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma.
    Zhao J; Liang Y; Yin Q; Liu S; Wang Q; Tang Y; Cao C
    Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27464025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantum dot-based sensitive detection of disease specific exosome in serum.
    Boriachek K; Islam MN; Gopalan V; Lam AK; Nguyen NT; Shiddiky MJA
    Analyst; 2017 Jun; 142(12):2211-2219. PubMed ID: 28534915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.
    Sogawa K; Takano S; Iida F; Satoh M; Tsuchida S; Kawashima Y; Yoshitomi H; Sanda A; Kodera Y; Takizawa H; Mikata R; Ohtsuka M; Shimizu H; Miyazaki M; Yokosuka O; Nomura F
    Br J Cancer; 2016 Oct; 115(8):949-956. PubMed ID: 27657339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-Derived Exosomal RNA From Fine-Needle Aspiration Supernatant as a Novel Liquid Biopsy for Molecular Diagnosis of Cancer.
    Li G; Liu D; Flandrin P; Zhang Y; Lambert C; Mallouk N; Cottier M
    Pathol Oncol Res; 2022; 28():1610344. PubMed ID: 35991837
    [No Abstract]   [Full Text] [Related]  

  • 32. Systematic review: exosomal microRNAs associated with pancreatic cancer for early detection and prognosis.
    Ye H; Wang H; Wang P; Song CH; Wang KJ; Dai LP; Shi JX; Liu XX; Sun CQ; Wang X; Peng Y; Chen XB; Zhang JY
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9351-9361. PubMed ID: 31773694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Alemar B; Izetti P; Gregório C; Macedo GS; Castro MA; Osvaldt AB; Matte U; Ashton-Prolla P
    Pancreas; 2016 Jan; 45(1):84-92. PubMed ID: 26262588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
    Papadakos SP; Dedes N; Pergaris A; Gazouli M; Theocharis S
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Situ Exosomal MicroRNA Determination by Target-Triggered SERS and Fe
    Jiang S; Li Q; Wang C; Pang Y; Sun Z; Xiao R
    ACS Sens; 2021 Mar; 6(3):852-862. PubMed ID: 33555177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introduction of Nanomaterials to Biosensors for Exosome Detection: Case Study for Cancer Analysis.
    Lee M; Kim J; Jang M; Park C; Lee JH; Lee T
    Biosensors (Basel); 2022 Aug; 12(8):. PubMed ID: 36005042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
    Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma.
    Li Z; Jiang P; Li J; Peng M; Zhao X; Zhang X; Chen K; Zhang Y; Liu H; Gan L; Bi H; Zhen P; Zhu J; Li X
    Oncogene; 2018 Jul; 37(28):3822-3838. PubMed ID: 29643475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma-a systematic review and meta-analysis.
    Bunduc S; Gede N; Váncsa S; Lillik V; Kiss S; Juhász MF; Erőss B; Szakács Z; Gheorghe C; Mikó A; Hegyi P
    Transl Res; 2022 Jun; 244():126-136. PubMed ID: 35066189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology.
    He M; Crow J; Roth M; Zeng Y; Godwin AK
    Lab Chip; 2014 Oct; 14(19):3773-80. PubMed ID: 25099143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.